LOMBARDI, CARLO MARIO
 Distribuzione geografica
Continente #
NA - Nord America 14.085
AS - Asia 8.088
EU - Europa 6.647
SA - Sud America 1.527
AF - Africa 192
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 8
Totale 30.571
Nazione #
US - Stati Uniti d'America 13.801
SG - Singapore 2.735
CN - Cina 2.704
UA - Ucraina 1.284
BR - Brasile 1.266
PL - Polonia 1.095
IT - Italia 1.024
HK - Hong Kong 908
DE - Germania 883
VN - Vietnam 530
FI - Finlandia 497
FR - Francia 487
GB - Regno Unito 388
IN - India 333
RU - Federazione Russa 312
TR - Turchia 305
IE - Irlanda 260
BD - Bangladesh 186
CA - Canada 137
SE - Svezia 109
AR - Argentina 97
MX - Messico 92
JP - Giappone 64
NL - Olanda 64
ZA - Sudafrica 55
IQ - Iraq 53
ES - Italia 47
SA - Arabia Saudita 43
BE - Belgio 38
ID - Indonesia 38
EC - Ecuador 37
PK - Pakistan 37
CZ - Repubblica Ceca 36
CO - Colombia 31
AT - Austria 29
NG - Nigeria 29
MA - Marocco 27
VE - Venezuela 25
CL - Cile 21
AU - Australia 19
LT - Lituania 18
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
JO - Giordania 16
PY - Paraguay 16
KE - Kenya 15
EG - Egitto 14
JM - Giamaica 14
UY - Uruguay 14
PH - Filippine 12
NP - Nepal 11
UZ - Uzbekistan 11
BG - Bulgaria 10
BO - Bolivia 9
LV - Lettonia 9
PA - Panama 9
PE - Perù 9
TH - Thailandia 9
AL - Albania 8
DZ - Algeria 8
KZ - Kazakistan 8
DO - Repubblica Dominicana 7
HN - Honduras 7
MY - Malesia 7
OM - Oman 7
SN - Senegal 7
AZ - Azerbaigian 6
CH - Svizzera 6
ET - Etiopia 6
EU - Europa 6
HU - Ungheria 6
IL - Israele 6
IR - Iran 6
MU - Mauritius 6
KR - Corea 5
MD - Moldavia 5
RO - Romania 5
SC - Seychelles 5
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
CR - Costa Rica 3
CY - Cipro 3
HR - Croazia 3
LB - Libano 3
LK - Sri Lanka 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CI - Costa d'Avorio 2
EE - Estonia 2
GE - Georgia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
Totale 30.544
Città #
Ashburn 1.360
Singapore 1.353
Fairfield 1.245
Warsaw 1.082
Jacksonville 922
Hong Kong 906
San Jose 881
Woodbridge 793
Beijing 637
Chandler 628
Houston 610
Seattle 540
The Dalles 522
Cambridge 521
Wilmington 505
Ann Arbor 481
Princeton 447
New York 407
Helsinki 323
Nanjing 313
Los Angeles 300
Dublin 259
Lauterbourg 259
Istanbul 243
Ho Chi Minh City 170
Munich 168
Dallas 167
Milan 152
São Paulo 121
Moscow 120
Buffalo 118
Pune 111
Des Moines 104
Hanoi 104
Brescia 102
Redondo Beach 102
Nanchang 100
Changsha 95
San Francisco 93
Shenyang 92
Shanghai 91
San Diego 88
Chicago 87
Dearborn 85
Hebei 78
Council Bluffs 76
London 75
Orem 74
Tianjin 74
Santa Clara 62
Frankfurt am Main 60
Jinan 60
Rome 60
Tokyo 60
Jiaxing 57
Chennai 50
Brooklyn 49
Montreal 49
Hangzhou 45
Turku 45
Nuremberg 43
Guangzhou 42
Boston 39
Romola 39
Rio de Janeiro 38
Poplar 36
Brussels 35
Kunming 35
Stockholm 35
Atlanta 34
Dong Ket 34
Kocaeli 34
Phoenix 34
Lancaster 33
Toronto 32
Mexico City 31
Brno 30
Abuja 29
Verona 29
Charlotte 28
Zhengzhou 28
Düsseldorf 27
Johannesburg 27
Ningbo 26
Boardman 25
Denver 25
Amsterdam 24
Manchester 24
Mumbai 24
Haiphong 23
Da Nang 22
Dhaka 21
Haikou 21
Washington 21
Belo Horizonte 20
Taizhou 20
Brasília 19
Riyadh 19
New Delhi 18
Bologna 17
Totale 19.922
Nome #
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 337
Can we improve the treatment of congestion in heart failure? 303
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 290
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 285
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 280
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 259
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 257
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 245
May 2020 at a glance: ischaemic heart failure and sex-related differences 240
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 208
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 205
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 201
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 199
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 194
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 193
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 193
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 187
Amino acids and derivatives, a new treatment of chronic heart failure? 185
Can we prevent or treat renal dysfunction in acute heart failure? 176
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 175
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 173
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 173
Neurohormonal activation in acute heart failure: results from VERITAS 171
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 165
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 160
A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure 160
Anemia and heart failure : a cause of progression or only a consequence? 159
2024 update in heart failure 158
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 158
Serelaxin a novel treatment for acute heart failure 158
Prognostic value of the absolute lymphocyte count in patients admitted for acute heart failure 153
Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health 152
Prognostic Evaluation Of The Ascending Aorta's Elastic Properties In Patients With Non-Ischemic Dilated Cardiomyopathy: An Echocardiographic Long-Term Follow-Up Study. 152
Heart failure and anemia: Effects on prognostic variables 151
N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure 151
The management of acute heart failure. 150
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 147
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 147
N-3 PUFA increase bioavailability and function of endothelial progenitor cells 147
Nutritional Deficiency in Patients with Heart Failure. 147
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 144
The Additional Role Of Diabetes Mellitus On Hypertension-Related Aortic Stiffness. 144
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 144
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. 142
The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy 141
Arterial Stiffness And Ventricular-Arterial Coupling In Hfref. 141
Apnee notturne e insufficienza cardiaca: un problema in via di soluzione. 139
Assessment of Congestion in Acute Heart Failure: When Simplicity Does Not Go Along With Accuracy 139
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 138
Body Mass Index Paradox In Acute Herat Failure 138
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 137
Updates in heart failure: what last year brought to us 137
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 135
Valore prognostico delle variazioni dell'indice di distribuzione dei volumi eritrocitari (RDW) nello scompenso cardiaco cronico. 135
Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure 135
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study 135
Six-year prognosis of diabetic patients with coronary artery disease. 134
Echocardiographic elastic properties of ascending aorta and their relationship with exercise capacity in patients with non-ischemic dilated cardiomyopathy 133
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 133
Acute heart failure 132
The need for evaluating right ventricular adaptation and ventriculo–arterial coupling 132
Acute heart failure: More questions than answers 131
Red cell distribution width and chronic heart failure: prognostic role beyond echocardiographic parameters. 130
Cardiorenal Interactions 129
In-hospital worsening heart failure in patients admitted for acute heart failure 129
Iron deficiency in heart failure 128
Decongestion, Arterial Stiffness And Ventricular-Arterial Coupling In Ahf. 127
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 126
Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? 126
Clinical characteristics and outcome of acute heart failure patients with mid-range ejection fraction. 126
In-hospital and long-term mortality for acute heart failure: analysis at the time of admission to the emergency department 126
Role of fluid retention in patients hospitalised for acute heart failure. 125
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. 125
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 125
Acute heart failure: The heart failure patient's journey-the vulnerable phase: Bibliography of one hundred key papers 125
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: early in vivo cardiovascular effects 125
Exercise performance is a prognostic indicator in elderly patients with chronic heart failure: Application of metabolic exercise cardiac kidney indexes score 125
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 125
Treatment of Patients Recently Admitted for Acute Heart Failure Based on NT-proBNP Plasma Levels Measurements. Results of a Prospective, Randomized, Single-centre Trial 124
Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome 124
Novel insight into the dangerous connection between diabetes and heart failure 124
Preoperative cardiac risks in noncardiac surgery: The role of coronary angiography 122
Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation 122
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 122
La terapia con inotropi del paziente con insufficienza cardiaca: oltre i farmaci tradizionali 121
Arrhythmias and cardiomyopathy: when arrhythmias come first 121
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 120
School and family-based interventions for promoting a healthy lifestyle among children and adolescents in Italy: A systematic review 120
Prediction of 1-year outcomes after an acute heart failure hospitalisation: importance of variables measured at the time of discharge. 118
Mode of death and hospitalization from the second follow-up serial infusions of nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes 117
Is there a role for ivabradine beyond its conventional use? 116
Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis 116
Carnosine: Potential aid for diabetes and cardiovascular disease 116
The prognostic value of serial troponin measurements in patients admitted for COVID-19 116
Role of nutrition in heart failure patients 115
Bisoprolol in the treatment of chronic heart failure: From pathophysiology to clinical pharmacology and trial results 115
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure 114
Beta 2 adrenergic receptors polymorphism influence: the effects of carvedinol in the patients with cronic heart failure. 113
Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial 113
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 112
Totale 15.386
Categoria #
all - tutte 157.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021149 0 0 0 0 0 0 0 0 0 0 0 149
2021/20221.621 72 245 42 119 48 77 42 142 80 197 166 391
2022/20231.749 262 92 27 125 168 468 5 165 274 14 84 65
2023/20242.064 124 32 210 172 123 422 92 77 410 50 47 305
2024/20254.656 46 60 76 534 461 388 511 238 406 370 943 623
2025/202610.110 1.032 1.365 746 1.423 1.026 676 1.537 434 573 856 431 11
Totale 30.958